BX Swiss TOP 30 CHF
1.278,99
PKT
+2,48
PKT
+0,19
%
Werbung
Analysen zu BX Swiss TOP 30 CHF-Werten
Datum | Rating | Analyst | |
---|---|---|---|
18.09.14 | Swiss Re Underweight | JP Morgan Chase & Co. | |
18.09.14 | Holcim buy | UBS AG | |
18.09.14 | Holcim buy | UBS AG | |
17.09.14 | Nestlé Hold | Société Générale Group S.A. (SG) | |
16.09.14 | Roche kaufen | Independent Research GmbH | |
16.09.14 | Novartis Underweight | Morgan Stanley | |
16.09.14 | Roche overweight | Morgan Stanley | |
15.09.14 | Novartis buy | Jefferies & Company Inc. | |
15.09.14 | Roche buy | Jefferies & Company Inc. | |
15.09.14 | UBS Equal weight | Barclays Capital | |
12.09.14 | Givaudan Sell | Goldman Sachs Group Inc. | |
11.09.14 | Holcim overweight | JP Morgan Chase & Co. | |
11.09.14 | Roche overweight | JP Morgan Chase & Co. | |
11.09.14 | Roche buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
11.09.14 | Novartis buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
10.09.14 | ABB (Asea Brown Boveri) Halten | Independent Research GmbH | |
10.09.14 | ABB (Asea Brown Boveri) overweight | Morgan Stanley | |
10.09.14 | Zurich Insurance neutral | Jefferies & Company Inc. | |
10.09.14 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
10.09.14 | UBS Underweight | JP Morgan Chase & Co. | |
10.09.14 | ABB (Asea Brown Boveri) Neutral | UBS AG | |
10.09.14 | UBS overweight | JP Morgan Chase & Co. | |
09.09.14 | Swiss Re Underweight | JP Morgan Chase & Co. | |
09.09.14 | Swiss Re buy | Deutsche Bank AG | |
09.09.14 | UBS buy | Deutsche Bank AG | |
09.09.14 | Novartis overweight | JP Morgan Chase & Co. | |
09.09.14 | Swiss Re Underperform | Credit Suisse Group | |
08.09.14 | Zurich Insurance Hold | Deutsche Bank AG | |
05.09.14 | UBS Equal-Weight | Morgan Stanley | |
05.09.14 | UBS overweight | Morgan Stanley | |
05.09.14 | Holcim overweight | JP Morgan Chase & Co. | |
05.09.14 | UBS Neutral | UBS AG | |
04.09.14 | Novartis Outperform | BNP PARIBAS | |
04.09.14 | Roche buy | UBS AG | |
03.09.14 | ABB (Asea Brown Boveri) overweight | Morgan Stanley | |
03.09.14 | Givaudan buy | UBS AG | |
03.09.14 | Novartis Halten | Independent Research GmbH | |
03.09.14 | ABB (Asea Brown Boveri) buy | Merrill Lynch & Co., Inc. | |
03.09.14 | ABB (Asea Brown Boveri) Neutral | UBS AG | |
02.09.14 | Nestlé Halten | Independent Research GmbH |